Ralph Lauren Corporation (RL): A Bull Case Theory
We came across a bullish thesis on Ralph Lauren Corporation on TickerTrends Research’s Substack.
Insider Monkey Blog
The Simply Good Foods Company (SMPL): A Bull Case Theory
We came across a bullish thesis on The Simply Good Foods Company on Daniel's Deep Dive’s Substack. In this article, we will summarize the bulls’ thesis on SMPL.
Victoria’s Secret & Co. (VSCO): A Bull Case Theory
We came across a bullish thesis on Victoria’s Secret & Co. on TickerTrends’s Substack.
Celanese Corporation (CE): A Bull Case Theory
We came across a bullish thesis on Celanese Corporation on Hidden Rock Capital's Newsletter’s Substack by Hidden Rock Capital.
Diversified Energy Company (DEC): A Bull Case Theory
We came across a bullish thesis on Diversified Energy Company on r/dividends by Leveraged_Lots. In this article, we will summarize the bulls’ thesis on DEC.
GoDaddy Inc. (GDDY): A Bull Case Theory
We came across a bullish thesis on GoDaddy Inc. on slo capital’s Substack by Justin.
Life360, Inc. (LIF): A Bull Case Theory
We came across a bullish thesis on Life360, Inc. on The Atomic Moat’s Substack by Rob H. | Atomic Moat.
William Blair Reiterates Buy on Erie Indemnity (ERIE)
In another development, Erie Indemnity Company (NASDAQ:ERIE) reported its Q4 2025 and full-year 2025 earnings results on February 23, 2026.
Morgan Stanley Maintains Hold on Assurant (AIZ) With $248 Target
On February 23, 2026, Morgan Stanley analyst Bob Huang maintained a Hold rating on Assurant, Inc. (NYSE:AIZ) with a price target of $248.
TD Cowen Reiterates Hold on Raymond James Financial (RJF) Shares
In another development, on February 19, 2026, the company announced that its Board of Directors had declared the quarterly cash dividend of $0.54 per share.
Raymond James Cuts Brown and Brown (BRO) Target by $8
On February 17, 2026, Raymond James lowered the price target on Brown & Brown, Inc. (NYSE:BRO) from $90 to $82 while keeping an Outperform rating on the shares.
Morgan Stanley Reiterates Buy on Globe Life (GL) Shares
Prior to this, on February 9, 2026, Michael Clay Majors, the company’s Executive Vice President and Chief Strategy Officer, engaged in a significant insider transaction, selling...
Barclays Cuts FactSet (FDS) Target to $210, Keeps Underweight Rating
On February 20, 2026, Barclays analyst Manav Patnaik lowered the price target on FactSet Research Systems Inc.
Ameriprise Financial (AMP) Executives Sell Shares in Insider Transactions Activity
Ameriprise Financial, Inc. (NYSE:AMP) witnessed notable insider activities in February.
Morgan Stanley Maintains Buy on Nasdaq (NDAQ) With $116 Target
On February 23, 2026, Morgan Stanley analyst Michael Cyprys maintained a Buy rating on Nasdaq, Inc. (NASDAQ:NDAQ) with a price target of $116.
UBS Cuts Target on Progressive (PGR), Maintains Neutral Rating
The Progressive Corporation (NYSE:PGR) saw mixed analyst sentiments on February 23, 2026.
Analysts Maintains Buy on Charles Schwab (SCHW)
The Charles Schwab Corporation (NYSE:SCHW) saw its Buy rating from Truist Financial reiterated by the firm’s analyst, David Smith CFA, on February 17, 2026.
Wells Fargo Reiterates Buy on Visa (V) Amid Expansion Announcements and Proposal Rejections
Separately, on the same day, Visa Inc. (NYSE:V) announced a multi-year renewal and expansion of its partnership with Oracle Red Bull Racing and Visa Cash App Racing Bulls.
Bank of America Maintains Buy on Synchrony Financial (SYF) Following Partnership Expansion
Prior to this, on February 18, 2026, the company announced the expansion of its partnership with Planet DDS by integrating CareCredit as the preferred financing solution across...
CME Group (CME) to Launch 24/7 Regulated Cryptocurrency Trading Access
On February 19, 2026, the company announced that its regulated cryptocurrency futures and options will begin trading 24 hours a day, seven days a week from May 29 onwards, pending...
Dentsply (XRAY) Rebounds 15.5% on Share Buyback
Dentsply bounced back by 15.50 percent on Friday to finish at $14.68 apiece, as investor sentiment was boosted by announcements of a share repurchase program, which overshadowed...
BioCryst (BCRX) Soars 10.8% on Swing to Profits
In an updated report, BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX) said that it swung to a net income of $263.86 million last year from an $88.88 million net loss in 2024.
Figs Inc. (FIGS) Soars to 4-Year High as Analyst Turns Bullish
Figs climbed to a nearly four-year high on Friday, as investors loaded portfolios after an investment firm turned bullish on the stock following its strong earnings performance...
Dell Technologies (DELL) Climbs 22% on Earnings Blowout, Dividend Hike
Dell Technologies soared by 21.93 percent on Friday to close at $148.08 apiece, as investor sentiment was boosted by a flurry of positive developments, including stellar earnings...
Paramount Skydance (PSKY) Climbs 20.8% as Netflix Backs Out of Warner Bros Bid
Paramount Skydance soared by 20.84 percent on Friday to finish at $13.51 apiece, after its rival firm, Netflix, surrendered from their billion-dollar bidding war for the acquisition...
Netflix (NFLX) Soars 13.7% After Dropping Warner Bros Bid
Netflix extended its winning streak to a fourth consecutive day on Friday, surging 13.75 percent to close at $96.24 apiece after dropping its offer to acquire Warner Bros Discovery...
11 Best Cancer Stocks to Invest In Now
Pharmaceutical companies are a blend of defensive income plays and growth opportunities.
Playtika Holding Corp. (PLTK) Posts Q4 2025 Earnings, Here’s What You Need to Know
Playtika Holding Corp. (NASDAQ:PLTK) is one of the Best Value Penny Stocks to Buy Now. Playtika Holding Corp.
Wall Street Cautious on Wipro Limited (WIT) Since Q3 2026 Earnings
Wipro Limited (NYSE:WIT) is one of the Best Value Penny Stocks to Buy Now.
TeraWulf Inc. (WULF) Announces Fiscal Q4 and Full-Year 2025 Financial Results
TeraWulf Inc. (NASDAQ:WULF) is one of the best hot stocks under $20 to buy. TeraWulf Inc.
Here’s What Analysts Are Saying About PG&E Corporation (PCG)
PG&E Corporation (NYSE:PCG) is one of the best hot stocks under $20 to buy.
Alignment Healthcare (ALHC) Reports Fiscal Q4 and Full Year 2025 Results
Alignment Healthcare, Inc. (NASDAQ:ALHC) is one of the best hot stocks under $20 to buy. Alignment Healthcare, Inc.
Wave Life Sciences Ltd. (WVE) Announces Fiscal Q4 and Full-Year 2025 Earnings
Wave Life Sciences Ltd. (NASDAQ:WVE) is one of the best hot stocks under $20 to buy. Wave Life Sciences Ltd.
What Does the Street Think About Lionsgate Studios Corp. (LION) Post Earnings?
Lionsgate Studios Corp. (NYSE:LION) is one of the best hot stocks under $20 to buy. On February 9, Wells Fargo reaffirmed a Buy rating on Lionsgate Studios Corp.
Clear Street Cuts PT on Cipher Digital (CIFR) to $32 From $34 – Here’s Why
Cipher Digital (NASDAQ:CIFR) is one of the best hot stocks under $20 to buy.
Why are Analysts Optimistic About Adaptive Biotechnologies (ADPT)?
Adaptive Biotechnologies Corporation (NASDAQ:ADPT) is one of the best hot stocks under $20 to buy.
Sibanye Stillwater (SBSW) Announces Financial Results for the Full Year and Six Months Ended December 31, 2025
Sibanye Stillwater Limited (NYSE:SBSW) is one of the best hot stocks under $20 to buy.
Is Ondas Inc. (ONDS) One of the Best Hot Stocks Under $20 to Buy?
Ondas Inc. (NASDAQ:ONDS) is one of the best hot stocks under $20 to buy. On February 23, Northland Securities maintained a Buy rating on Ondas Inc.
The Boeing Company (BA) Builds Momentum with Wide-Body and 737 MAX Orders from Vietnam
The Boeing Company (NYSE:BA) is one of the best manufacturing stocks to invest in now.
Caterpillar Inc. (CAT) Strengthens Data Mining Technology Portfolio After Record Sales
Caterpillar Inc. (NYSE:CAT) is one of the best manufacturing stocks to invest in now. On February 17, Caterpillar Inc.
RBC Capital Maintains a Sector Perform Rating on Beam Therapeutics (BEAM), Here’s Why
Beam Therapeutics Inc. (NASDAQ:BEAM) is one of the top gene therapy stocks to buy according to hedge funds.
Guggenheim Lifts PT on Krystal Biotech (KRYS) to $284 From $224
Krystal Biotech, Inc. (NASDAQ:KRYS) is one of the top gene therapy stocks to buy according to hedge funds.
Here’s What Analysts Are Saying About CRISPR Therapeutics AG (CRSP)
CRISPR Therapeutics AG (NASDAQ:CRSP) is one of the top gene therapy stocks to buy according to hedge funds.
Intellia Therapeutics (NTLA) Announces Fiscal Q4 and Full Year 2025 Financial Results
Intellia Therapeutics, Inc. (NASDAQ:NTLA) is one of the top gene therapy stocks to buy according to hedge funds. Intellia Therapeutics, Inc.
Novartis (NVS) Announces Plans to Establish a New Radioligand Therapy Manufacturing Site in Denton, Texas
Novartis AG (NYSE:NVS) is one of the top gene therapy stocks to buy according to hedge funds.
Where is 4D Molecular Therapeutics (FDMT) Headed According to the Street?
4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) is one of the top gene therapy stocks to buy according to hedge funds. 4D Molecular Therapeutics, Inc.
Bernstein Lifts PT on BioMarin Pharmaceutical (BMRN) to $94 From $90, Here’s Why
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is one of the top gene therapy stocks to buy according to hedge funds.
Here’s What Analysts Are Saying About Vertex Pharmaceuticals (VRTX)
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is one of the top gene therapy stocks to buy according to hedge funds.
Wolfe Research Initiates Coverage of UniQure (QURE) With a Peer Perform Rating
UniQure (NASDAQ:QURE) is one of the top gene therapy stocks to buy according to hedge funds.
Hedge Fund Resource Center
